Suven, with Cohance and more, wants to become a CDMO powerhouse: Annaswamy Vaidheesh, executive chairman
Suven-Cohance Lifesciences merger announced to create 1st listed PE-led contract manufacturer in Indian pharma
Advent Launches New Brand For Its API Platform
Advent launches Cohance Lifesciences, a new brand identity for its API platform
Global private equity fund Advent International on Monday said it will be acquiring a controlling stake in pharma sector-focused Avra Laboratories, in a deal which values the company promoted by A V Rama Rao at USD 100 million.
Formerly known as Zandu Chemicals Ltd, ZCL is in the active pharmaceutical ingredients or API space in India. The Parikh family had acquired ZCL from Zandu Pharmaceuticals Ltd in 2008 at an equity valuation of Rs 12.5 crore, the Parikh family said in a statement.
Nihar and his father Ajay Parikh had floated ZCL Chemicals when Zandu Pharma was acquired by Emami in 2008
Parikh family, founder and promoters of ZCL Chemicals Limited announced that they have sold the entire stake in the company to Advent International, one of the largest and most experienced global private equity investors, for an equity value of Rs. 2,000 crore.
ZCL Chemicals Ltd is all set to serve up benchmark returns for Morgan Stanley PE Asia as the investor gets ready to exit the active...
Bulk-drugs manufacturer ZCL Chemicals Ltd, which had initiated talks last year to provide Morgan Stanley Private Equity Asia with...